Cryo-EM structure of an amyloid fibril formed by full-length human prion protein

Prion diseases are caused by the misfolding of prion protein (PrP). Misfolded PrP forms protease-resistant aggregates in vivo (PrP Sc ) that are able to template the conversion of the native form of the protein (PrP C ), a property shared by in vitro–produced PrP fibrils. Here we produced amyloid fi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature structural & molecular biology 2020-06, Vol.27 (6), p.598-602
Hauptverfasser: Wang, Li-Qiang, Zhao, Kun, Yuan, Han-Ye, Wang, Qiang, Guan, Zeyuan, Tao, Jing, Li, Xiang-Ning, Sun, Yunpeng, Yi, Chuan-Wei, Chen, Jie, Li, Dan, Zhang, Delin, Yin, Ping, Liu, Cong, Liang, Yi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Prion diseases are caused by the misfolding of prion protein (PrP). Misfolded PrP forms protease-resistant aggregates in vivo (PrP Sc ) that are able to template the conversion of the native form of the protein (PrP C ), a property shared by in vitro–produced PrP fibrils. Here we produced amyloid fibrils in vitro from recombinant, full-length human PrP C (residues 23–231) and determined their structure using cryo-EM, building a model for the fibril core comprising residues 170−229. The PrP fibril consists of two protofibrils intertwined in a left-handed helix. Lys194 and Glu196 from opposing subunits form salt bridges, creating a hydrophilic cavity at the interface of the two protofibrils. By comparison with the structure of PrP C , we propose that two α-helices in the C-terminal domain of PrP C are converted into β-strands stabilized by a disulfide bond in the PrP fibril. Our data suggest that different PrP mutations may play distinct roles in modulating the conformational conversion. A cryo-EM structure of amyloid fibrils formed in vitro with recombinant human PrP provides insights into fibril architecture and the potential role of disease mutations.
ISSN:1545-9993
1545-9985
DOI:10.1038/s41594-020-0441-5